NCT03979001

Brief Summary

Obstructive sleep apnea syndrome (OSA) is thought to lead to systemic vascular lesions that may be preceded by early microvascular lesions in the eyes and in particular in the retina. The improvement of ophthalmological imaging techniques by OCTangiography allows a precise non-invasive study of the retinal microvascular network. This new rapid and non-invasive retinal imaging tool could reveal micro-vascular lesions related to OSA. To the investigator's knowledge, this would be the first OCT-angiography description of a cohort of patients with OSA. If these results are confirmed, it would be interesting to study the correlation between these micro-vascular lesions and the cardiovascular risk of his patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 7, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

January 6, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2024

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

4.6 years

First QC Date

June 5, 2019

Last Update Submit

February 12, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Measurement of macular and peri-papillary retinal vascular density of the superficial and deep capillary plexuses

    Change from baseline at 24 months

  • Measurement of macular and peri-papillary retinal infusion density of the superficial and deep capillary plexuses

    Change from baseline at 24 months

  • Measurement of the surface of the macular avascular zone of the superficial and deep capillary plexuses

    Change from baseline at 24 months

Study Arms (2)

Patients

Patients referred for polysomnography diagnosis of obstructive sleep apnea syndrome

Other: complete ophthalmological examination

Controls

Person without obstructive sleep apnea syndrome

Interventions

collection: * ophthalmological history and current treatments * occular tension measurement * measurement of visual acuity (Snellen chart) * Axial length measurement * Photograph of the posterior segment of the eye * 3x3 and 6x6 macular and papillary OCT angiography

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients seen for sleep apnea screening by a pulmonologist and referred for polysomnography diagnosis of obstructive sleep apnea syndrome

You may qualify if:

  • person who has given oral consent
  • person who can be followed throughout the study
  • adult
  • Patient group:
  • \- Patient seen in sleep apnea screening consultation by a pulmonologist and referred for polysomnography diagnosis of OSA
  • Control Group:
  • \- Person initially without obstructive sleep apnea syndrome

You may not qualify if:

  • a person who is not affiliated to or not a beneficiary of the national health insurance system
  • person subject to a measure of legal protection (curatorship, guardianship)
  • person subject to a safeguard of justice
  • pregnant, parturient or breastfeeding woman
  • adult incapable or unable to consent
  • person with a contraindication to Tropicamide or Neosynephrine
  • person with a history of eye disease affecting ocular circulation (examples: acute anterior ischemic optic neuropathy, retinal central artery occlusion, retinal central vein occlusion, diabetic retinopathy, glaucoma, uncontrolled hypertonia, AMD, severe myopia...)
  • Control Group:
  • person with a history of chronic lung problems (e.g. COPD, chronic respiratory failure, etc.)
  • person with at least one of the following risk factors for obstructive sleep apnea syndrome:
  • Obesity with IMC≥30
  • Alcohol consumption \> 3 glasses per day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Dijon Bourogne

Dijon, 21000, France

Location

Related Publications (1)

  • Germanese C, Georges M, Bonniaud P, Goueslard K, Arnould L, Creuzot Garcher C, Gabrielle PH. Characterization of Retinal Microvascular Changes in Obstructive Sleep Apnea Using OCT Angiography: Data from the Obstructive Sleep Apnea and Retinal Microvascular NETwork Study. Ophthalmology. 2026 Feb 2:S0161-6420(26)00059-X. doi: 10.1016/j.ophtha.2026.01.030. Online ahead of print.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2019

First Posted

June 7, 2019

Study Start

January 6, 2020

Primary Completion

August 22, 2024

Study Completion

August 22, 2024

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations